17-Allylamino-17-demethoxygeldanamycin induces downregulation of critical Hsp90 protein clients and results in cell cycle arrest and apoptosis of human urinary bladder cancer cells
<p>Abstract</p> <p>Background</p> <p>17-Allylamino-17-demethoxygeldanamycin (17-AAG), a benzoquinone ansamycin antibiotic, specifically targets heat shock protein 90 (Hsp90) and interferes with its function as a molecular chaperone that maintains the structural and func...
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2010-09-01
|
Series: | BMC Cancer |
Online Access: | http://www.biomedcentral.com/1471-2407/10/481 |
id |
doaj-f5939282cc354e38926b995407912347 |
---|---|
record_format |
Article |
spelling |
doaj-f5939282cc354e38926b9954079123472020-11-25T00:26:18ZengBMCBMC Cancer1471-24072010-09-0110148110.1186/1471-2407-10-48117-Allylamino-17-demethoxygeldanamycin induces downregulation of critical Hsp90 protein clients and results in cell cycle arrest and apoptosis of human urinary bladder cancer cellsKarkoulis Panagiotis KStravopodis Dimitrios JMargaritis Lukas HVoutsinas Gerassimos E<p>Abstract</p> <p>Background</p> <p>17-Allylamino-17-demethoxygeldanamycin (17-AAG), a benzoquinone ansamycin antibiotic, specifically targets heat shock protein 90 (Hsp90) and interferes with its function as a molecular chaperone that maintains the structural and functional integrity of various protein clients involved in cellular signaling. In this study, we have investigated the effect of 17-AAG on the regulation of Hsp90-dependent signaling pathways directly implicated in cell cycle progression, survival and motility of human urinary bladder cancer cell lines.</p> <p>Methods</p> <p>We have used MTT-based assays, FACS analysis, Western blotting, semi-quantitative RT-PCR, immunocytochemistry and scratch-wound assay in RT4, RT112 and T24 human urinary bladder cancer cell lines.</p> <p>Results</p> <p>We have demonstrated that, upon 17-AAG treatment, bladder cancer cells are arrested in the G1 phase of the cell cycle and eventually undergo apoptotic cell death in a dose-dependent manner. Furthermore, 17-AAG administration was shown to induce a pronounced downregulation of multiple Hsp90 protein clients and other downstream effectors, such as IGF-IR, Akt, IKK-α, IKK-β, FOXO1, ERK1/2 and c-Met, resulting in sequestration-mediated inactivation of NF-κB, reduced cell proliferation and decline of cell motility.</p> <p>Conclusions</p> <p>In total, we have clearly evinced a dose-dependent and cell type-specific effect of 17-AAG on cell cycle progression, survival and motility of human bladder cancer cells, due to downregulation of multiple Hsp90 clients and subsequent disruption of signaling integrity.</p> http://www.biomedcentral.com/1471-2407/10/481 |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Karkoulis Panagiotis K Stravopodis Dimitrios J Margaritis Lukas H Voutsinas Gerassimos E |
spellingShingle |
Karkoulis Panagiotis K Stravopodis Dimitrios J Margaritis Lukas H Voutsinas Gerassimos E 17-Allylamino-17-demethoxygeldanamycin induces downregulation of critical Hsp90 protein clients and results in cell cycle arrest and apoptosis of human urinary bladder cancer cells BMC Cancer |
author_facet |
Karkoulis Panagiotis K Stravopodis Dimitrios J Margaritis Lukas H Voutsinas Gerassimos E |
author_sort |
Karkoulis Panagiotis K |
title |
17-Allylamino-17-demethoxygeldanamycin induces downregulation of critical Hsp90 protein clients and results in cell cycle arrest and apoptosis of human urinary bladder cancer cells |
title_short |
17-Allylamino-17-demethoxygeldanamycin induces downregulation of critical Hsp90 protein clients and results in cell cycle arrest and apoptosis of human urinary bladder cancer cells |
title_full |
17-Allylamino-17-demethoxygeldanamycin induces downregulation of critical Hsp90 protein clients and results in cell cycle arrest and apoptosis of human urinary bladder cancer cells |
title_fullStr |
17-Allylamino-17-demethoxygeldanamycin induces downregulation of critical Hsp90 protein clients and results in cell cycle arrest and apoptosis of human urinary bladder cancer cells |
title_full_unstemmed |
17-Allylamino-17-demethoxygeldanamycin induces downregulation of critical Hsp90 protein clients and results in cell cycle arrest and apoptosis of human urinary bladder cancer cells |
title_sort |
17-allylamino-17-demethoxygeldanamycin induces downregulation of critical hsp90 protein clients and results in cell cycle arrest and apoptosis of human urinary bladder cancer cells |
publisher |
BMC |
series |
BMC Cancer |
issn |
1471-2407 |
publishDate |
2010-09-01 |
description |
<p>Abstract</p> <p>Background</p> <p>17-Allylamino-17-demethoxygeldanamycin (17-AAG), a benzoquinone ansamycin antibiotic, specifically targets heat shock protein 90 (Hsp90) and interferes with its function as a molecular chaperone that maintains the structural and functional integrity of various protein clients involved in cellular signaling. In this study, we have investigated the effect of 17-AAG on the regulation of Hsp90-dependent signaling pathways directly implicated in cell cycle progression, survival and motility of human urinary bladder cancer cell lines.</p> <p>Methods</p> <p>We have used MTT-based assays, FACS analysis, Western blotting, semi-quantitative RT-PCR, immunocytochemistry and scratch-wound assay in RT4, RT112 and T24 human urinary bladder cancer cell lines.</p> <p>Results</p> <p>We have demonstrated that, upon 17-AAG treatment, bladder cancer cells are arrested in the G1 phase of the cell cycle and eventually undergo apoptotic cell death in a dose-dependent manner. Furthermore, 17-AAG administration was shown to induce a pronounced downregulation of multiple Hsp90 protein clients and other downstream effectors, such as IGF-IR, Akt, IKK-α, IKK-β, FOXO1, ERK1/2 and c-Met, resulting in sequestration-mediated inactivation of NF-κB, reduced cell proliferation and decline of cell motility.</p> <p>Conclusions</p> <p>In total, we have clearly evinced a dose-dependent and cell type-specific effect of 17-AAG on cell cycle progression, survival and motility of human bladder cancer cells, due to downregulation of multiple Hsp90 clients and subsequent disruption of signaling integrity.</p> |
url |
http://www.biomedcentral.com/1471-2407/10/481 |
work_keys_str_mv |
AT karkoulispanagiotisk 17allylamino17demethoxygeldanamycininducesdownregulationofcriticalhsp90proteinclientsandresultsincellcyclearrestandapoptosisofhumanurinarybladdercancercells AT stravopodisdimitriosj 17allylamino17demethoxygeldanamycininducesdownregulationofcriticalhsp90proteinclientsandresultsincellcyclearrestandapoptosisofhumanurinarybladdercancercells AT margaritislukash 17allylamino17demethoxygeldanamycininducesdownregulationofcriticalhsp90proteinclientsandresultsincellcyclearrestandapoptosisofhumanurinarybladdercancercells AT voutsinasgerassimose 17allylamino17demethoxygeldanamycininducesdownregulationofcriticalhsp90proteinclientsandresultsincellcyclearrestandapoptosisofhumanurinarybladdercancercells |
_version_ |
1725344837386895360 |